EP0759976A4 - The isolation and production of catalytic antibodies using phage technology - Google Patents

The isolation and production of catalytic antibodies using phage technology

Info

Publication number
EP0759976A4
EP0759976A4 EP94919078A EP94919078A EP0759976A4 EP 0759976 A4 EP0759976 A4 EP 0759976A4 EP 94919078 A EP94919078 A EP 94919078A EP 94919078 A EP94919078 A EP 94919078A EP 0759976 A4 EP0759976 A4 EP 0759976A4
Authority
EP
European Patent Office
Prior art keywords
isolation
production
catalytic antibodies
phage technology
phage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94919078A
Other languages
German (de)
French (fr)
Other versions
EP0759976A1 (en
Inventor
Rodger G Smith
John Mccafferty
David Chiswell
Michael J Darsley
Kevin Fitzgerald
John H Kenten
Mark T Martin
Richard C Titmas
Richard O Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IGEN International Inc
Original Assignee
IGEN International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IGEN International Inc filed Critical IGEN International Inc
Publication of EP0759976A1 publication Critical patent/EP0759976A1/en
Publication of EP0759976A4 publication Critical patent/EP0759976A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP94919078A 1994-03-30 1994-03-30 The isolation and production of catalytic antibodies using phage technology Withdrawn EP0759976A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003420 WO1995027045A1 (en) 1994-03-30 1994-03-30 The isolation and production of catalytic antibodies using phage technology

Publications (2)

Publication Number Publication Date
EP0759976A1 EP0759976A1 (en) 1997-03-05
EP0759976A4 true EP0759976A4 (en) 2001-02-07

Family

ID=22242396

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94919078A Withdrawn EP0759976A4 (en) 1994-03-30 1994-03-30 The isolation and production of catalytic antibodies using phage technology

Country Status (4)

Country Link
EP (1) EP0759976A4 (en)
JP (1) JPH10507341A (en)
AU (1) AU695406B2 (en)
WO (1) WO1995027045A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386802T1 (en) 1997-06-12 2008-03-15 Novartis Int Pharm Ltd ARTIFICIAL ANTIBODIES POLYPEPTIDES
AU5122499A (en) 1998-07-27 2000-02-21 Genentech Inc. Improved transformation efficiency in phage display through modification of a coat protein
AU7786701A (en) 2000-07-11 2002-01-21 Res Corp Technologies Inc Artificial antibody polypeptides
DE60224720D1 (en) 2001-11-22 2008-03-06 Univ Keio Re
AU2003243436A1 (en) 2002-06-06 2003-12-22 Shohei Koide Reconstituted polypeptides
FI20022048A0 (en) 2002-11-18 2002-11-18 Valtion Teknillinen Non-competitive immunoassay for small assays

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014430A1 (en) * 1989-05-16 1990-11-29 Scripps Clinic And Research Foundation A new method for tapping the immunological repertoire
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
US5258289A (en) * 1990-09-05 1993-11-02 Davis Claude G Method for the selecting of genes encoding catalytic antibodies

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014430A1 (en) * 1989-05-16 1990-11-29 Scripps Clinic And Research Foundation A new method for tapping the immunological repertoire
US5258289A (en) * 1990-09-05 1993-11-02 Davis Claude G Method for the selecting of genes encoding catalytic antibodies
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MCCAFFERTY J ET AL: "SELECTION AND RAPID PURIFICATION OF MURINE ANTIBODY FRAGMENTS THAT BIND A TRANSITION-STATE ANALOG BY PHAGE DISPLAY", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY,US,CLIFTON, NJ, vol. 47, 1994, pages 157 - 173, XP002913520, ISSN: 0273-2289 *
See also references of WO9527045A1 *

Also Published As

Publication number Publication date
AU695406B2 (en) 1998-08-13
EP0759976A1 (en) 1997-03-05
AU7014194A (en) 1995-10-23
JPH10507341A (en) 1998-07-21
WO1995027045A1 (en) 1995-10-12

Similar Documents

Publication Publication Date Title
ZA965078B (en) Catalyst and process for the preparation of hydrocarbons
EP0708482A3 (en) BiCDMOS process technology and structures
HUP9900422A3 (en) Novel protein and methods for the production of the same
IL104384A0 (en) Detection of catalytic antibodies
AU5422696A (en) Nox catalyst and method of using the same
EP0882673A4 (en) Ultraviolet-screening composite particulate and process for the production thereof
GB2323285B (en) Orifice couplings parts therefor and methods of production
HU9402359D0 (en) Coupling for flanged pipes, process for connecting the flanges and use of the coupling
AU1203399A (en) Catalytic structure and method of making the same
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
IL109656A0 (en) Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby
IL111186A0 (en) Process for the preparation of microspheres and microspheres made thereby
EP0718256A3 (en) Ceramic sliding member and process of fabricating the same
EP0935612A4 (en) Precursors of catalytic antibodies
EP0759976A4 (en) The isolation and production of catalytic antibodies using phage technology
HU9600320D0 (en) Process and new intermediates for the preparation of triazolinon-derivatives
EP0761721A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0484546A4 (en) Microcapsule and method of making the same
EP0761719A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0761720A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
ZA947564B (en) Production of antigens
GB2260276B (en) Combination catalytic converter and muffler and method of making the same
GB9517538D0 (en) Production and therapeutic combinations, of antibodies
KR0157225B1 (en) Permeability brick and method of making the same
HU9602959D0 (en) Spider neurotoxins and method of producing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IGEN INTERNATIONAL, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 9/00 A, 7C 07K 16/00 B, 7A 61K 38/43 B

A4 Supplementary search report drawn up and despatched

Effective date: 20001222

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20011024

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 16/00 B

Ipc: 7C 12N 9/00 A

RTI1 Title (correction)

Free format text: THE ISOLATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING PHAGE TECHNOLOGY

RTI1 Title (correction)

Free format text: ISOLATION AND PRODUCTION OF CATALYTIC ANTIBODIES USING TWO AFFINITY PEPTIDES IN TANDEM

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060308